Research Analysts’ Upgrades for November 18th (AMLX, APD, AUTL, BFAM, BNS, CBRL, CVS, DCOM, FNV, FUTU)

Research Analysts’ upgrades for Monday, November 18th:

Amylyx Pharmaceuticals (NASDAQ:AMLX) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $11.00 target price on the stock, up from their previous target price of $3.00.

Air Products and Chemicals (NYSE:APD) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. The firm currently has $375.00 price target on the stock.

Autolus Therapeutics (NASDAQ:AUTL) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. The Goldman Sachs Group, Inc. currently has $7.60 target price on the stock, up from their previous target price of $7.00.

Bright Horizons Family Solutions (NYSE:BFAM) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. BMO Capital Markets currently has $125.00 price target on the stock, down from their previous price target of $137.00.

Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating.

Cracker Barrel Old Country Store (NASDAQ:CBRL) was upgraded by analysts at Argus from a hold rating to a buy rating. They currently have $52.00 target price on the stock.

CVS Health (NYSE:CVS) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. Wells Fargo & Company currently has $66.00 price target on the stock, up from their previous price target of $60.00.

Dime Community Bancshares (NASDAQ:DCOM) was upgraded by analysts at Stephens from an equal weight rating to an overweight rating. They currently have $39.00 target price on the stock, up from their previous target price of $30.00.

Franco-Nevada (NYSE:FNV) (TSE:FNV) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.

Franco-Nevada (NYSE:FNV) (TSE:FNV) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating.

Futu (NASDAQ:FUTU) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $115.00 price target on the stock, up from their previous price target of $70.00.

Genesco (NYSE:GCO) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Robinhood Markets (NASDAQ:HOOD) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. The firm currently has $40.00 target price on the stock.

Hewlett Packard Enterprise (NYSE:HPE) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. They currently have $29.00 price target on the stock, up from their previous price target of $23.00.

MBIA (NYSE:MBI) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. They currently have $9.00 target price on the stock, up from their previous target price of $6.50.

Monolithic Power Systems (NASDAQ:MPWR) was upgraded by analysts at Loop Capital from a hold rating to a buy rating. The firm currently has $660.00 target price on the stock.

Moderna (NASDAQ:MRNA) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. The firm currently has $58.00 target price on the stock.

Roku (NASDAQ:ROKU) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $90.00 target price on the stock, up from their previous target price of $70.00.

ServisFirst Bancshares (NYSE:SFBS) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

United Fire Group (NASDAQ:UFCS) was upgraded by analysts at Piper Sandler from an underweight rating to a neutral rating. Piper Sandler currently has $26.00 price target on the stock, up from their previous price target of $19.00.

Voyager Therapeutics (NASDAQ:VYGR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.